Michael Nanna, MD, MHS, FSCAI, FACC

Dr. Nanna is an Interventional Cardiologist specializing in coronary interventions, with a focus on the care of older adults living with multiple chronic conditions. Dr. Nanna graduated Stony Brook University School of Medicine as a member of both the Alpha Omega Alpha and the Arnold P. Gold Foundation honor societies. He completed his training in internal medicine and served as a chief resident at Yale New Haven Hospital before training in Cardiology and Interventional Cardiology at Duke University Medical Center. In addition, he completed a Master of Health Sciences in Clinical Research degree through the Clinical Research Training Program at Duke University School of Medicine.

His research interests center around improving risk prediction, treatment utilization and shared decision-making for older adults at risk for or living with cardiovascular disease. He is the recipient of several awards including a GEMSSTAR (Grants for Early Medical/Surgical Specialists’ Transition to Aging Research) award from the NIH National Institute on Aging to address the medical needs of older adult patients at high risk for cardiovascular disease and dementia, as well as a geriatric cardiology professional development award from the American College of Cardiology Foundation supported by the George F. and Ann Harris Bellows Foundation. In collaboration with the Yale Pepper Center, he is the national PI for the LIVEBETTER trial, a randomized trial of anti-anginal therapies in older adults with stable ischemic heart disease and multiple chronic conditions funded by the Patient-Centered Outcomes Research Institute (PCORI). Dr. Nanna currently serves as an Associate Editor at the American Heart Journal & JACC Advances. He has served as a reviewer for a number of scholarly journals including JAMA, JACC, and Circulation.